Contact Us 888-901-2226
Donate Now

Statement on Planned Merck BCG Production Facility to Expand Capacity

October 14, 2020

From Andrea Maddox-Smith, CEO:

Today’s news that Merck has announced construction of a new manufacturing facility to significantly expand its production capacity for TICE® BCG is welcome news for bladder cancer patients. We appreciate Merck’s commitment to increase the supply of a treatment that is in such high demand for bladder cancer patients. The Bladder Cancer Advocacy Network will continue to work collaboratively and tirelessly with the medical research and pharmaceutical industries to improve outcomes for bladder cancer patients.

Click here to read more news and updates about BCG.


Listen now to our
"Bladder Cancer Matters"
Episode 1: What's Up with BCG?


Bladder Cancer Matters Podcast


=> Click here to listen <=